|
Evogene Ltd., a
subsidiary of Compugen, is a pioneer in overcoming the limitations of
both classical breeding and modern biotechnology in order to generate
improved crops and new agricultural biotechnology products in an
economically efficient manner. This objective is accomplished by
integrating computational biology and plant genomics with classical
breeding to create high-throughput platforms that generate improved
plants and plant derived products by accelerating, directing and
mimicking the natural evolution process.
Compugen (NASDAQ:
CGEN) is a pioneer in the merging of computational technologies with
biology, chemistry and medicine to enhance drug discovery and
development. This unique capability is a proven basis for providing high
value products and services to leading biotechnology and pharmaceutical
companies and for in-house discovery. |
